India’s largest medical diagnostics company Dr Lal PathLabs will invest close to Rs 150 crore by March 2010 for its expansion plans.
“We will launch greenfield diagnostics centres and also acquire suitable pathological laboratories all over the country,” company’s CMD Arvind Lal told Business Standard.
Besides, the company is also bullish on the Hospital Laboratory Management (HLM) space, under which it will comprehensively manage the diagnostics functions of the individual hospitals.“We already have tie-ups with 4 hospitals and will soon forge alliances with 20 more hospitals, including some prominent hospital chains,” Lal added. At present, the company has 40 labs and 700 sample collection centres in India. It is amongst the few organised pathological chains in the country, others being Religare, Metropolis and Piramal Diagnostics.